Public Charity

MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION

MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION, of UNIONDALE, NY, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $37.2M in revenue, $27.2M in expenses, $91.5M in total assets. 225 publicly reported grants to this organization, totaling roughly $16.6M, appear in IRS filings.

EIN: 311611837 UNIONDALE, NY Single Organization Support NTEE: P11 Latest filing: 2025
Total Revenue$37.2M
Total Expenses$27.2M
Total Assets$91.5M
Grant Records225
Funding Total$16.6M
Filing Years2021–2025

Mission

THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.THE LUSTGARTEN FOUNDATION IS BOLDLY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY25, THE FOUNDATION AWARDED $18 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.

Where $100 goes at Marc Lustgarten Pancreatic Cancer Foundation

How Marc Lustgarten Pancreatic Cancer Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.

$84 Programs the work itself
$7 Management running the organization
$9 Fundraising raising the next dollar

Inside the $84 for programs

$76
Research program
91% of program spending · Reported in the filing: 10 grants; 51 grants
$5
Public education and information program
6% of program spending
$3
Professional education program
3% of program spending
Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

DIRECTOR Aaron Kantoff
VICE CHAIRMAN Adam Silver
CHAIRMAN Andrew Lustgarten
VP RESEARCH Andrew Rakeman
DIRECTOR Charles R Schueler
CFO Faisal Jawaid

Officer compensation and complete director data available with membership.

Top Grant Purposes

General Support
$10,470,439 143 grants
Health & Medicine
$2,832,079 45 grants
Human & Social Services
$2,054,309 12 grants
Fundraising & Sponsorship
$90,000 3 grants
Research & Policy
$47,500 4 grants

Financial Trends

Year Revenue Expenses Assets
2025 $37.2M $27.2M $91.5M
2024 $22.7M $31.0M $75.8M
2023 $18.3M $28.7M $78.6M
2022 $30.4M $33.8M $78.5M
2021 $24.5M $21.7M $96.6M

Between 2021 and 2025, reported annual revenue grew from $24.5M to $37.2M (+52%), with total assets most recently reported at $91.5M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION

Complete financials, all 225 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time